Ponsegromab Crashes Out in Frailer Heart Failure Patients

(MedPage Today) — MINNEAPOLIS — Disappointingly, a growth differentiation factor 15 (GDF-15) neutralizer not only failed to improve functional outcomes in heart failure (HF) but was associated with harm in a trial that was terminated early…

Source link : https://www.medpagetoday.com/meetingcoverage/hfsa/117753

Author :

Publish date : 2025-10-02 16:11:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Ponsegromab Crashes Out in Frailer Heart Failure Patients

Proton Therapy Does Not Reduce Side Effects in OPSCC

Drop in This Birth Defect Parallels Decline in Maternal Smoking

Related Posts

‘It’s Not How a Responsible Scientist Acts’: What We Heard This Week

Pain Patients Often Feel Out of Options. Acupuncture Hides in Plain Sight.

Trump and Republicans Once More Face a Tough Political Fight Over Obamacare

Extinct animals in Prehistoric Planet: Ice Age make it a must-watch

‘It sounds dramatic – but singing class saved by life’

Is Chemo Driving Late Cardiac Events in Older Cancer Survivors?

‘It’s Not How a Responsible Scientist Acts’: What We Heard This Week

Pain Patients Often Feel Out of Options. Acupuncture Hides in Plain Sight.

Trump and Republicans Once More Face a Tough Political Fight Over Obamacare

Extinct animals in Prehistoric Planet: Ice Age make it a must-watch

‘It sounds dramatic – but singing class saved by life’

Is Chemo Driving Late Cardiac Events in Older Cancer Survivors?

Potassium in Patients with ICDs; mRNA Flu Vaccine; Canceled NIH Funding for Trials

The FDA Commissioner Is Missing the Point of Advisory Committees

Categories

Archives